Joshua B Cohen - Net Worth and Insider Trading
Joshua B Cohen Net Worth
The estimated net worth of Joshua B Cohen is at least $19 Million dollars as of 2024-11-05. Joshua B Cohen is the Co-CEO of Amylyx Pharmaceuticals Inc and owns about 3,220,569 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $19 Million. Details can be seen in Joshua B Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua B Cohen has not made any transactions after 2024-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joshua B Cohen
Joshua B Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua B Cohen owns 1 companies in total, including Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of Joshua B Cohen’s form 4 insider trades.
Insider Ownership Summary of Joshua B Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2024-09-30 | director & Co-Chief Executive Officer |
Joshua B Cohen Latest Holdings Summary
Joshua B Cohen currently owns a total of 1 stock. Joshua B Cohen owns 3,220,569 shares of Amylyx Pharmaceuticals Inc (AMLX) as of September 30, 2024, with a value of $19 Million.
Latest Holdings of Joshua B Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2024-09-30 | 3,220,569 | 5.75 | 18,502,169 |
Holding Weightings of Joshua B Cohen
Joshua B Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua B Cohen has made a total of 5 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 18,589 shares on September 30, 2024, which brought Joshua B Cohen around $59,485.
Insider Trading History of Joshua B Cohen
- 1
Joshua B Cohen Trading Performance
Joshua B Cohen Ownership Network
Ownership Network List of Joshua B Cohen
Ownership Network Relation of Joshua B Cohen
Joshua B Cohen Owned Company Details
What does Amylyx Pharmaceuticals Inc do?
Who are the key executives at Amylyx Pharmaceuticals Inc?
Joshua B Cohen is the director & Co-Chief Executive Officer of Amylyx Pharmaceuticals Inc. Other key executives at Amylyx Pharmaceuticals Inc include director & Co-Chief Executive Officer Justin B. Klee , Chief Legal Officer Gina Mazzariello , and Chief Financial Officer James M Frates .
Amylyx Pharmaceuticals Inc (AMLX) Insider Trades Summary
Over the past 18 months, Joshua B Cohen made 3 insider transaction in Amylyx Pharmaceuticals Inc (AMLX) with a net sale of 28,565. Other recent insider transactions involving Amylyx Pharmaceuticals Inc (AMLX) include a net sale of 29,706 shares made by Gina Mazzariello , a net purchase of 2,992 shares made by James M Frates , and a net sale of 28,565 shares made by Justin B. Klee .
In summary, during the past 3 months, insiders sold 57,329 shares of Amylyx Pharmaceuticals Inc (AMLX) in total and bought 190,000 shares, with a net purchase of 132,671 shares. During the past 18 months, 150,063 shares of Amylyx Pharmaceuticals Inc (AMLX) were sold and 199,000 shares were bought by its insiders, resulting in a net purchase of 48,937 shares.
Amylyx Pharmaceuticals Inc (AMLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amylyx Pharmaceuticals Inc Insider Transactions
Joshua B Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua B Cohen. You might contact Joshua B Cohen via mailing address: C/o Amylyx Pharmaceuticals, Inc., 43 Thorndike Street, Cambridge Ma 02141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
